Home / Blog
Global Brain Computer Interface (BCI) Market Size Was 125.21 Million US$ In 2018
Wednesday, 06 May, 2020
A brain–computer interface, sometimes called a neural-control interface, mind-machine interface, direct neural interface, or brain–machine interface, is a direct communication pathway between an enhanced or wired brain and an external device. Brain-computer interface (BCI) is a collaboration between a brain and a device that enables signals from the brain to direct some external activity.

GIR analysts predict that the global Brain Computer Interface (BCI) market is valued at 125.21 million USD in 2018 and is expected to reach 283.04 million USD by the end of 2025, growing at a CAGR of 12.43% between 2019 and 2025. 

According to the Segmentation of types, all the market of Brain Computer Interface (BCI) can be divided as follows: 
The first main kind is Non Invasive BCI, it hold a comparatively larger share in global market, which accounts for about 72.41% in 2018.
Another main kinds is Invasive BCI, for many companies, Invasive BCI technology is attractive because it can implement more complex functions in the future. But its technical difficulty is also greater. Invasive BCI technology share the rest 27.59% market share in 2018.

From the view of region, North America have a larger market share in 2018 which account for 60.28%, and will witness a stable growth in following years. Europe and China hold a market share of 24.89% and 4.18% will still play an important role which cannot be ignored. Any changes from Europe and China might affect the development trend of Brain Computer Interface (BCI). Japan, Rest of Asia-Pacific and Others also play important roles in global market, but it will witness the comparatively low market share within selected regions.

The world leading players in the Brain Computer Interface (BCI) market are NeuroPace, Inc, Emotiv Inc, InteraXon, NeuroSky, Inc., Blackrock Microsystems LLC, Compumedics Limited, Mindmaze SA, Advanced Brain Monitoring, G.TEC, Neuroelectrics, Brain Products GmbH, ANT Neuro B.V, BrainCo, Artinis Medical Systems BV and so on. These Top companies currently account for more than 70% of the total market share and are expected to retain their dominating hold over the market during the forecast period. As consumer interest increases, this market will attract other major companies which want to extend their brand equity.